Colgate expands oral care portfolio with new Colgate Sensitive Pro-Relief
NEW YORK — In an effort to bring faster relief to the millions of consumers who suffer from tooth sensitivity, Colgate-Palmolive has developed the new Colgate Sensitive Pro-Relief toothpaste.
“Sensitivity is more than just an inconvenience, it’s a common condition that can cause unwanted pain,” said William DeVizio, VP global technology for Colgate-Palmolive. “New Colgate Sensitive Pro-Relief toothpaste is clinically proven to deliver faster and long-lasting sensitivity relief versus a leading sensitive toothpaste. 2 Its proprietary formula penetrates to the source of pain, the nerve, to soothe the pain faster, shielding the nerve to prevent the pain from coming back.”
Tooth sensitivity is an oral condition that affects up to 57% of consumers worldwide, the manufacturer stated. Cold air, a hot drink or a sweet dessert can trigger acute sensitivity pain. Likewise, the touch of a dental instrument can make routine dental visits unbearable. This discomfort may lead sensitivity sufferers to avoid regular checkups.
“Building on the success of its companion in-office professional product, Colgate Sensitive Pro-Relief toothpaste offers an innovative approach to treating tooth sensitivity and will help consumers control their tooth sensitivity and live life to the fullest,” said Nigel Burton, president of global oral care for Colgate-Palmolive.
Pharmacists’ integral role in administering flu vaccines asserted in report
ALEXANDRIA, Va. — In line with National Immunization Awareness Month, a new report has highlighted the role pharmacists play in administering flu vaccinations.
A recent public-private partnership campaign in Palm Beach County, Fla. — which involved the Palm Beach County Health Department, Palm Beach County Pharmacy Association and several local pharmacies — stressed the fact that pharmacists are "an integral part of the nation’s ‘first line resource’ for health and wellness and can extend the reach for public health initiatives," according to a results report that was published in the Journal of Public Health Management and Practice.
“The public-private collaboration between health departments and community pharmacists could improve individual and family readiness, increase access to trained and trusted professionals and strengthen overall preparedness and community resilience,” the article stated.
Commenting on the article, the National Association of Chain Drug Stores president and CEO Steve Anderson said that the partnership is further drives home the message that pharmacists play a critical role in the healthcare delivery system.
"Pharmacists in all 50 states can administer the flu vaccine to patients, offering yet another important opportunity for patient-pharmacist interaction," Anderson said. "The success of this program described in the Journal of Public Health Management and Practice provides additional support for efforts to further expand the age ranges and types of vaccinations for which pharmacists have authority. It also demonstrates yet again the unsurpassed value of pharmacy in improving patient health and lowering healthcare costs."
Kinney announces inoculation program for 2011-2012 flu season
GOUVERNEUR, N.Y. — Kinney Drugs will provide flu immunizations to patients by appointment during the 2011-2012 flu season.
This year’s flu vaccine is designed to protect against the three most common types of flu viruses, influenza A H3N2, influenza B and H1N1.
Kinney operates stores in New York and Vermont.